Skip to content

About US
About LB-102
Pipeline
Publications
Investors
Careers
Contact Us

LB Pharma R&D Day: Advancing LB‑102 with a Focus on Schizophrenia Treatment

October 27, 2026

Time: 2:00 PM EDT
Location: Midtown, New York and Live Webcast

About the Event

view ALL Events

About US
About LB-102
Pipeline
Publications
Investors
Careers
Contact Us

About US
About LB-102
Pipeline
Publications
Investors
Careers
Contact Us

All Rights Reserved.

About Us
Management
Board of Directors
Scientific Advisory Board
Careers
Contact Us

About LB-102
Pipeline
About Schizophrenia
Publications

Investors Overview
News
Events
Corporate Governance
SEC Filings
Stock Information
Analyst Coverage
Investor FAQs

© 2026 LB Pharmaceuticals, a clinical-stage biopharmaceutical company developing novel therapies for the treatment of neuropsychiatric diseases, including schizophrenia.

Expanded Access Policy
Privacy Policy

Scroll to Top